Immuno-oncology Monitoring

MAKING IMMUNO-ONCOLOGY TREATMENTS SAFER, LESS EXPENSIVE, MORE ACCESSIBLE

physIQ predicts physiological changes from a personalized baseline, often ahead of current Standards of Care – empowering more timely and effective intervention by clinicians.

Meaningful Safety Signals

Obtain meaningful safety signals earlier, with fewer false positives.

Richer Safety Endpoints

Assess richer safety endpoint data sooner to make more informed trial decisions.

Real Time Alerts

Provide medical monitors with real-time alerts and the ability to quickly assess events.

Increase Patient Diversity

Proactive safety measures enable recruitment of a more diverse patient population, increasing access to novel therapies for underserved patients.

More Quantifiable Measures

Obtain a richer dataset of quantifiable measures vs. subjective assessments for benefit / risk analysis by health authorities.

Avoid Safety Holds

Avoid safety holds and navigate those that do occur with relevant data demonstrating whether an event is treatment-related.

IMMUNO-ONCOLOGY